Emotion-induced brain activation across the menstrual cycle in individuals with premenstrual dysphoric disorder and associations to serum levels of progesterone-derived neurosteroids
- PMID: 37055419
- PMCID: PMC10101953
- DOI: 10.1038/s41398-023-02424-3
Emotion-induced brain activation across the menstrual cycle in individuals with premenstrual dysphoric disorder and associations to serum levels of progesterone-derived neurosteroids
Abstract
Premenstrual dysphoric disorder (PMDD) is a debilitating disorder characterized by severe mood symptoms in the luteal phase of the menstrual cycle. PMDD symptoms are hypothesized to be linked to an altered sensitivity to normal luteal phase levels of allopregnanolone (ALLO), a GABAA-modulating progesterone metabolite. Moreover, the endogenous 3β-epimer of ALLO, isoallopregnanolone (ISO), has been shown to alleviate PMDD symptoms through its selective and dose-dependent antagonism of the ALLO effect. There is preliminary evidence showing altered recruitment of brain regions during emotion processing in PMDD, but whether this is associated to serum levels of ALLO, ISO or their relative concentration is unknown. In the present study, subjects with PMDD and asymptomatic controls underwent functional magnetic resonance imaging (fMRI) in the mid-follicular and the late-luteal phase of the menstrual cycle. Brain responses to emotional stimuli were investigated and related to serum levels of ovarian steroids, the neurosteroids ALLO, ISO, and their ratio ISO/ALLO. Participants with PMDD exhibited greater activity in brain regions which are part of emotion-processing networks during the late-luteal phase of the menstrual cycle. Furthermore, activity in key regions of emotion processing networks - the parahippocampal gyrus and amygdala - was differentially associated to the ratio of ISO/ALLO levels in PMDD subjects and controls. Specifically, a positive relationship between ISO/ALLO levels and brain activity was found in PMDD subjects, while the opposite was observed in controls. In conclusion, individuals with PMDD show altered emotion-induced brain responses in the late-luteal phase of the menstrual cycle which may be related to an abnormal response to physiological levels of GABAA-active neurosteroids.
© 2023. The Author(s).
Conflict of interest statement
MB is a member of the advisory board for Asarina Pharma. ISP has occasionally served on advisory boards or acted as invited speaker at scientific meetings for Asarina Pharma, Bayer Health Care, Gedeon Richter, Peptonics, Shire/Takeda, Sandoz, and Lundbeck A/S. No conflicts of interest are declared by the other authors.
Figures




Similar articles
-
Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder.J Neuroendocrinol. 2018 Feb;30(2). doi: 10.1111/jne.12553. J Neuroendocrinol. 2018. PMID: 29072794 Review.
-
Luteal phase sertraline treatment of premenstrual dysphoric disorder (PMDD): Effects on markers of hypothalamic pituitary adrenal (HPA) axis activation and inflammation.Psychoneuroendocrinology. 2024 Nov;169:107145. doi: 10.1016/j.psyneuen.2024.107145. Epub 2024 Jul 24. Psychoneuroendocrinology. 2024. PMID: 39096755
-
Transcription of GABAA receptor subunits in circulating monocytes and association to emotional brain function in premenstrual dysphoric disorder.Transl Psychiatry. 2025 Jul 23;15(1):255. doi: 10.1038/s41398-025-03465-6. Transl Psychiatry. 2025. PMID: 40701967 Free PMC article.
-
GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder.Psychoneuroendocrinology. 2024 Feb;160:106684. doi: 10.1016/j.psyneuen.2023.106684. Epub 2023 Nov 30. Psychoneuroendocrinology. 2024. PMID: 38091917 Free PMC article.
-
GABAA Receptor-Modulating Steroids in Relation to Women's Behavioral Health.Curr Psychiatry Rep. 2015 Nov;17(11):92. doi: 10.1007/s11920-015-0627-4. Curr Psychiatry Rep. 2015. PMID: 26396092 Review.
Cited by
-
Biomarkers of reproductive psychiatric disorders.Br J Psychiatry. 2025 Jun;226(6):352-368. doi: 10.1192/bjp.2025.134. Epub 2025 Jun 20. Br J Psychiatry. 2025. PMID: 40538358 Free PMC article. Review.
-
Dimensional Affective Sensitivity to Hormones across the Menstrual Cycle (DASH-MC): A transdiagnostic framework for ovarian steroid influences on psychopathology.Mol Psychiatry. 2025 Jan;30(1):251-262. doi: 10.1038/s41380-024-02693-4. Epub 2024 Aug 15. Mol Psychiatry. 2025. PMID: 39143323 Review.
-
Therapeutic potential of rutin in premenstrual depression: evidence from in vivo and in vitro studies.Front Pharmacol. 2025 Jan 14;15:1525753. doi: 10.3389/fphar.2024.1525753. eCollection 2024. Front Pharmacol. 2025. PMID: 39877393 Free PMC article.
-
Plasma γ-Aminobutyric Acid (GABA) Concentrations in Lactating Holstein Cows during Thermoneutral and Heat Stress Conditions and Their Relationships with Circulating Glucose, Insulin and Progesterone Levels.Vet Sci. 2024 Mar 21;11(3):137. doi: 10.3390/vetsci11030137. Vet Sci. 2024. PMID: 38535871 Free PMC article.
-
Isoallopregnanolone Inhibits Estrus Cycle-Dependent Aggressive Behavior.Biomolecules. 2023 Jun 20;13(6):1017. doi: 10.3390/biom13061017. Biomolecules. 2023. PMID: 37371597 Free PMC article.
References
-
- Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD) Psychoneuroendocrinology. 2003;28:1–23. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical